Profund Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $307K | Buy |
+125,856
| New | +$252K | 0.01% | 735 |
|
|
2025
Q1 | – | Sell |
-70,325
| Closed | -$150K | – | 994 |
|
|
2024
Q4 | $150K | Buy |
70,325
+7,691
| +12% | +$19K | 0.01% | 1044 |
|
|
2024
Q3 | $175K | Sell |
62,634
-13,526
| -18% | -$36.1K | 0.01% | 1070 |
|
|
2024
Q2 | $177K | Sell |
76,160
-44,899
| -37% | -$132K | 0.01% | 1003 |
|
|
2024
Q1 | $541K | Buy |
+121,059
| New | +$505K | 0.02% | 546 |
|
|
2023
Q4 | – | Sell |
-130,639
| Closed | -$414K | – | 1131 |
|
|
2023
Q3 | $414K | Sell |
130,639
-6,593
| -5% | -$28.9K | 0.02% | 520 |
|
|
2023
Q2 | $682K | Buy |
137,232
+12,621
| +10% | +$68.3K | 0.04% | 416 |
|
|
2023
Q1 | $616K | Buy |
+124,611
| New | +$799K | 0.04% | 443 |
|
|
2022
Q3 | – | Sell |
-10,229
| Closed | -$117K | – | 925 |
|
|
2022
Q2 | $117K | Sell |
10,229
-1,014
| -9% | -$9K | 0.01% | 962 |
|
|
2022
Q1 | $102K | Sell |
11,243
-1,249
| -10% | -$13K | ﹤0.01% | 1321 |
|
|
2021
Q4 | $186K | Sell |
12,492
-1,488
| -11% | -$26.3K | 0.01% | 1295 |
|
|
2021
Q3 | $359K | Buy |
13,980
+631
| +5% | +$15K | 0.01% | 818 |
|
|
2021
Q2 | $348K | Buy |
13,349
+55
| +0.4% | +$1.57K | 0.01% | 932 |
|
|
2021
Q1 | $469K | Sell |
13,294
-1,292
| -9% | -$43.6K | 0.02% | 635 |
|
|
2020
Q4 | $368K | Buy |
14,586
+1,454
| +11% | +$47.4K | 0.02% | 704 |
|
|
2020
Q3 | $495K | Sell |
13,132
-1,946
| -13% | -$73.4K | 0.03% | 458 |
|
|
2020
Q2 | $646K | Buy |
15,078
+4,867
| +48% | +$176K | 0.04% | 353 |
|
|
2020
Q1 | $199K | Sell |
10,211
-4,089
| -29% | -$97.4K | 0.01% | 653 |
|
|
2019
Q4 | $372K | Buy |
14,300
+1,712
| +14% | +$47.2K | 0.02% | 780 |
|
|
2019
Q3 | $343K | Buy |
+12,588
| New | +$359K | 0.02% | 836 |
|
Other funds holding ALLO
P
TGA
VCM
